Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
3.280
-0.230 (-6.55%)
At close: May 14, 2025, 4:00 PM
3.269
-0.011 (-0.34%)
After-hours: May 14, 2025, 7:43 PM EDT

Protagenic Therapeutics Market Cap

Protagenic Therapeutics has a market cap or net worth of $1.76 million as of May 14, 2025. Its market cap has decreased by -75.73% in one year.

Market Cap
1.76M
Enterprise Value
882.13K
1-Year Change
-75.73%
Ranking
Category
Stock Price
$3.28

Market Cap Chart

Since February 16, 2016, Protagenic Therapeutics's market cap has increased from $399.62K to $1.76M, an increase of 341.21%. That is a compound annual growth rate of 17.42%.

History

DateMarket Cap% Change
May 13, 20251.89M-43.33%
Dec 31, 20243.33M-24.17%
Dec 29, 20234.39M-36.50%
Dec 30, 20226.91M-70.56%
Dec 31, 202123.48M4.03%
Dec 27, 2017 Pro Pro
Feb 16, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 669.76B
Johnson & Johnson 357.16B
AbbVie 332.08B
Novo Nordisk 291.59B
UnitedHealth Group 282.47B
Abbott Laboratories 224.53B
Novartis AG 209.81B
AstraZeneca 209.59B
Market Cap Rankings